ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
A phase 3 trial of Pafolacianine in Lung cancer, run by On Target Laboratories, LLC, completed.
Overview
ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting is a phase 3 interventional study registered as NCT04241315 by On Target Laboratories, LLC, with 112 participants recorded, started 2020-03-26 and reaching its primary completion in 2021-10-07. Interventions recorded: OTL38 for Injection, Near infrared camera imaging system. Conditions recorded: Lung Neoplasms, Lung Cancer.
Linked to the drug Pafolacianine because the registry names it among its interventions and Lung cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialCYTALUX™for the Intraoperative Imaging of Prostate Cancer
Shares Pafolacianine and the tag pipeline.
- TrialSingle Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer
Shares Pafolacianine and the tag pipeline.
- TrialDocetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Shares Lung cancer (all types) and the tag pipeline.
- TrialMithramycin for Lung, Esophagus, and Other Chest Cancers
Shares Lung cancer (all types) and the tag pipeline.
- TrialCombination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
Shares Lung cancer (all types) and the tag pipeline.
- TrialNivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Shares Lung cancer (all types) and the tag pipeline.
- TechnologyIntraoperative fluorescence and Cerenkov imaging systems (SPY, Firefly, LumiSystem, LightPath)
Shares On Target Laboratories, Pafolacianine.
- TechnologyOptical & fluorescence imaging
Shares On Target Laboratories, Pafolacianine.